Cite
HARVARD Citation
Namikawa, K. et al. (2018). Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study. European journal of cancer. pp. 114-126. [Online].